LEVOTHYROXINE
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00451 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 15 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | familial hyperlipidemia | TxGNN Knowledge Graph |
| 2 | familial papillary thyroid carcinoma with renal papillary neoplasia | TxGNN Knowledge Graph |
| 3 | differentiated thyroid carcinoma | TxGNN Knowledge Graph |
| 4 | myxedema | TxGNN Knowledge Graph |
| 5 | thyroid cancer | TxGNN Knowledge Graph |
| 6 | goiter (disease) | TxGNN Knowledge Graph |
| 7 | thyroid gland disease | TxGNN Knowledge Graph |
| 8 | congenital hypothyroidism | TxGNN Knowledge Graph |
| 9 | thyroid gland undifferentiated (anaplastic) carcinoma | TxGNN Knowledge Graph |
| 10 | Hashimoto thyroiditis | TxGNN Knowledge Graph |
| 11 | medullary thyroid gland carcinoma | TxGNN Knowledge Graph |
| 12 | familial papillary or follicular thyroid carcinoma | TxGNN Knowledge Graph |
| 13 | hyperlipidemia | TxGNN Knowledge Graph |
| 14 | hypothyroidism | TxGNN Knowledge Graph |
| 15 | familial thyroid carcinoma | TxGNN Knowledge Graph |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.